Mylan Pharmaceuticals Inc. et al. vs. Novartis AG et al.
Explore the PTAB proceeding IPR2015-00265 filed by Mylan Pharmaceuticals Inc. et al. on 2014-11-13. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2015-00265
Filing Date
2014-11-13
Accorded Filing Date
2014-11-13
Institution Decision Date
2015-04-10
Last Modified Date
2022-10-10
Proceeding Type
IPR
Termination Date
2015-09-28
Trial Status
Final Written Decision
Parties & Counsel
Petitioner
Mylan Pharmaceuticals Inc. et al.
Represented By
Reisman, Josephet alPatent Owner / Respondent
Novartis AG et al.
Represented By
Mandra, Raymondet alPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
1 Total
Proceeding Status
Final Written Decision
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (1)
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° RadarMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
Noven Pharmaceuticals, Inc. et al. v. Novartis AG et al.
Novartis Pharmaceuticals Corporation v. Amneal Pharmaceuticals LLC
Novartis Pharmaceuticals Corporation v. Dr. Reddy's Laboratories, Ltd.
Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc.
Novartis Pharmaceuticals Corporation v. Noven Pharmaceuticals Inc.
Novartis Pharmaceuticals Corporation v. Noven Pharmaceuticals Inc.
Novartis Pharmaceuticals Corporation v. Alvogen Pine Brook Inc.
Novartis Pharmaceuticals Corporation v. Actavis Inc.
Novartis Pharmaceuticals Corporation v. Watson Laboratories Inc.
Novartis Pharmaceuticals Corporation v. Par Pharmaceutical Inc.